CGM vs finger-stick for type 2 diabetes in pregnancy
Part of Hormones & metabolism clinical trials.
This trial tests if using a continuous glucose monitor (CGM) helps manage blood sugar better than finger-stick checks in pregnant women with type 2 diabetes. It aims to see if CGM leads to better sugar control and possibly healthier outcomes for you and your baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with one baby (not twins or more)
- Your baby has no known birth defects
- You have type 2 diabetes (not type 1)
- You started prenatal care before 20 weeks of pregnancy
- You are not allergic to insulin
- You are able and willing to wear a continuous glucose monitor
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a CGM (a small sensor that tracks blood sugar) can help manage type 2 diabetes during pregnancy better than standard care. It is for women who have type 2 diabetes and are pregnant with one baby.
This trial tests whether using a continuous glucose monitor (a small sensor that checks blood sugar throughout the day) helps pregnant women with type 2 diabetes manage their blood sugar better. It may offer a more convenient way to track levels without frequent finger pricks.
This study compares a continuous glucose monitor (CGM) to standard finger-prick testing for managing gestational diabetes. It aims to see if the CGM can improve blood sugar control and maternal outcomes.
This trial tests whether using a continuous glucose monitor (CGM) during pregnancy and after delivery helps women with gestational diabetes. It aims to see if the Dexcom G7 can improve health outcomes for both you and your baby.
This study tests whether using a continuous glucose monitor during pregnancy is useful for people with type 2 diabetes. It may help track blood sugar levels more closely to support safer pregnancy care.
This trial tests whether a continuous glucose monitor can help women with type 2 diabetes who are pregnant and need insulin therapy. It aims to improve blood sugar control and pregnancy outcomes.
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.